Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,379.38
(
-0.38%
)
News Focus
News Focus
Post# of 517743
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

nidan7500

Send PM Follow Ignore
Followers 57
Posts 10479
Boards Moderated 0
Alias Born 09/21/2016

nidan7500

Re: falconer66a post# 325847

Saturday, 08/14/2021 8:13:43 AM

Saturday, August 14, 2021 8:13:43 AM

Post# of 517743
falconer

My proclamations of blarcamesine safety and efficacy are valid. But the even greater matter is the inability of Anavex opponents to lay out and describe information that negates those contentions. If there were any safety problems, we’d have heard about them. The silence on that matter is definitive, altogether. Next, and finally, will be the Rett study data, conclusively and universally proving therapeutic efficacy.



Great stuff and exactly the kind of DD we must keep. "Effective and safe", can't do better than that. Thanks.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News